[HTML][HTML] Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation …
QL Zhang, JJ Yang, HS Zhang - Biomedicine & Pharmacotherapy, 2019 - Elsevier
Doxorubicin (DOX) is a wide spectrum antitumor drug. However, its clinical application is
limited due to the cardiotoxicity. Carvedilol (CAR) is a β-blocker used to treat high blood …
limited due to the cardiotoxicity. Carvedilol (CAR) is a β-blocker used to treat high blood …
Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis …
QL Zhang, JJ Yang, HS Zhang - Biomedicine & …, 2019 - pubmed.ncbi.nlm.nih.gov
Doxorubicin (DOX) is a wide spectrum antitumor drug. However, its clinical application is
limited due to the cardiotoxicity. Carvedilol (CAR) is a β-blocker used to treat high blood …
limited due to the cardiotoxicity. Carvedilol (CAR) is a β-blocker used to treat high blood …
Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis …
QL Zhang, JJ Yang, HS Zhang - Biomedicine & Pharmacotherapy …, 2018 - europepmc.org
Doxorubicin (DOX) is a wide spectrum antitumor drug. However, its clinical application is
limited due to the cardiotoxicity. Carvedilol (CAR) is a β-blocker used to treat high blood …
limited due to the cardiotoxicity. Carvedilol (CAR) is a β-blocker used to treat high blood …